Literature DB >> 17041361

Transient elevation of the tumor markers CA 15-3 and CASA as markers of interstitial lung disease rather than underlying malignancy in dermatomyositis sine myositis.

Richard C W Wong1, Scott Brown, Belinda E Clarke, Sandra Klingberg, Paul V Zimmerman.   

Abstract

A 37-year-old woman with severe interstitial lung disease associated with dermatomyositis sine myositis is reported. A thoracoscopic lung biopsy revealed organizing diffuse alveolar damage. Significantly elevated serum levels of the tumor markers CA 15-3 and CASA (cancer-associated serum antigen) were detected, but no evidence of an underlying malignancy (including breast and ovarian) was found on serial clinical and radiologic examinations. These levels gradually normalized as the interstitial lung disease responded to a combination of cyclophosphamide and corticosteroids. The use of the CA 15-3 and CASA assays to measure serum levels of the highly glycosylated, high-molecular-weight mucin MUC1 in interstitial lung disease has not been previously described. Clinicians should therefore be aware that elevation of these tumor markers may reflect the presence of interstitial lung disease rather than an underlying malignancy in patients with dermatomyositis, especially if the levels normalize after successful treatment of the lung disease.

Entities:  

Year:  2002        PMID: 17041361     DOI: 10.1097/00124743-200208000-00005

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  3 in total

1.  CA 15.3: a marker of disease activity in sarcoidosis.

Authors:  Yasemin Türk; Clara Shapiro; Gert-Jan Braunstahl
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 2.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

3.  Association between CA 15‑3 and progression of interstitial lung disease in a case of coexisting systemic sclerosis and recurrent breast cancer: A case report.

Authors:  Masahiro Ohara; Yumiko Koi; Tatsunari Sasada; Keiko Kajitani; Seishi Mizuno; Ai Takata; Atsuko Okamoto; Ikuko Nagata; Mie Sumita; Kaita Imachi; Mayumi Watanabe; Yutaka Daimaru; Yusuke Yoshida
Journal:  Mol Clin Oncol       Date:  2022-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.